AI offerings supporting scalable ECG analysis, visualization, and report generation Combination of single-lead wearable ...

Newly cleared AccurECG 2.0 is enterprise-grade, device-agnostic ECG interpretation platform designed for scale, accelerated turnaround, and flexible customer integrations. AccurECG is AccurKardia’s ...

Smartwatch-based monitoring using both photoplethysmography and ECG could improve detection of new-onset atrial fibrillation ...

Dutch trial establishes feasibility of screening approach in routine specialty care ...

Remote screening with a smartwatch detected new-onset atrial fibrillation more often vs. standard care among patients at ...

In the peer-reviewed study, researchers were able to identify almost four times as many instances of the disease using an ...

While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

NimbleHeart, the Campell, California-based producer of clinical-grade mobile cardiac monitoring devices, announced that its fully reusable ECG device has received FDA clearance and will soon be ...

DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either ...

The ECG devices market has experienced significant growth due to the introduction of advanced technologies in cardiovascular disease (CVD) testing. New monitoring technologies have improved disease ...

A new compact, lightweight, gel-free and waterproof electrocardiogram (ECG) sensor offers more comfort and less skin irritation, compared to similar heart monitoring devices on the market. ECGs help ...